miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response

The identification of the molecular mechanisms involved in the establishment of the resistant phenotype represents a critical need for the development of new strategies to prevent or overcome cancer resistance to anti-neoplastic treatments.

Bibliographic Details
Main Authors: Cataldo, Alessandra, Cheung, Douglas G., Balsari, Andrea, Tagliabue, Elda, Coppola, Vincenzo, Iorio, Marilena V., Palmieri, Dario, Croce, Carlo M.
Format: Online
Language:English
Published: Impact Journals LLC 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808033/